These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32659676)

  • 1. Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS.
    Franzoni S; Morbioli L; Turtoro A; Solazzo L; Greco A; Arbitrio M; Tagliaferri P; Tassone P; Di Martino MT; Breda M
    J Pharm Biomed Anal; 2020 Sep; 188():113451. PubMed ID: 32659676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC-MS/MS.
    Franzoni S; Vezzelli A; Turtoro A; Solazzo L; Greco A; Tassone P; Di Martino MT; Breda M
    J Pharm Biomed Anal; 2018 Feb; 150():300-307. PubMed ID: 29268195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalysis of an oligonucleotide and its metabolites by liquid chromatography-tandem mass spectrometry.
    Deng P; Chen X; Zhang G; Zhong D
    J Pharm Biomed Anal; 2010 Aug; 52(4):571-9. PubMed ID: 20153130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
    Jemal M; Schuster A; Whigan DB
    Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine.
    Dubbelman AC; Tibben M; Rosing H; Gebretensae A; Nan L; Gorman SH; Robertson P; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():92-100. PubMed ID: 22426286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
    Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and method stability study of a LC-MS method to quantify leuprolide (Hormone analog) in human plasma.
    Skiba M; Fatmi S; Elkasri N; Karrout Y; Lahiani-Skiba M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1160():122345. PubMed ID: 32920482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Yamane N; Tozuka Z; Sugiyama Y; Tanimoto T; Yamazaki A; Kumagai Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):118-28. PubMed ID: 17804306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel LC-MS/MS method for the simultaneous quantification of topiramate and its main metabolites in human plasma.
    Milosheska D; Roškar R
    J Pharm Biomed Anal; 2017 May; 138():180-188. PubMed ID: 28214451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a LC-MS/MS assay for quantification of cisplatin in rat plasma and urine.
    Shaik AN; Altomare DA; Lesko LJ; Trame MN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():243-249. PubMed ID: 28162967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
    Abdallah OM; Abdel-Megied AM; Gouda AS
    Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a quantitative LC-MS/MS method for the simultaneous determination of ceftolozane and tazobactam in human plasma and urine.
    Putnam WC; Kallem RR; Edpuganti V; Subramaniyan I; Hall RG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1159():122354. PubMed ID: 32905989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an LC-MS/MS method for the quantitative analysis of milciclib in human and mouse plasma, mouse tissue homogenates and tissue culture medium.
    Martínez-Chávez A; Tibben MM; Broeders J; Rosing H; Schinkel AH; Beijnen JH
    J Pharm Biomed Anal; 2020 Oct; 190():113516. PubMed ID: 32784092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a highly sensitive LC-MS/MS assay for the quantification of arginine vasopressin in human plasma and urine: Application in preterm neonates and child.
    Zhang D; Rios DR; Tam VH; Chow DS
    J Pharm Biomed Anal; 2014 Oct; 99():67-73. PubMed ID: 25072843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-tandem mass spectrometry based method development and validation of S016-1271 (LR8P), a novel cationic antimicrobial peptide for its application to pharmacokinetic studies.
    Puttrevu SK; Laxman TS; Tripathi AK; Yadav AK; Verma SK; Mishra A; Pradhan R; Verma NK; Ghosh JK; Bhatta RS
    J Pharm Biomed Anal; 2019 May; 169():116-126. PubMed ID: 30851514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an LC-MS/MS method for the quantitative determination of mavoglurant (AFQ056) in human plasma.
    Jakab A; Winter S; Raccuglia M; Picard F; Dumitras S; Woessner R; Mistry S; Chudasama J; Guttikar S; Kretz O
    Anal Bioanal Chem; 2013 Jan; 405(1):215-23. PubMed ID: 23064707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.